Retatrutide is an investigational compound not approved by the FDA for any indication
Home Gym Equipment Checklist for Beginners (2026) Beef Grading Explained: What Prime, Choice, and Select Actually Mean at the Store Navigating Newborn Diarrhea: Understanding the Formula Options Understanding Aortic Aneurysms: What to Know About Aorta Ascendens Ectasia Exploring Effective Medications for SIADH Management
The primary endpoints are alteration of transcriptomic profile of tongue tissue as changes in expression level from baseline to follow-up after 16 weeks of treatment, measured by RNA sequencing, and change in taste sensitivity as detected by chemical gustometry
Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing
In controlled laboratory settings, Retatrutide (GLP3-R) is studied for its interaction across multiple metabolic receptor pathways, including GLP-related signaling and additional receptor-mediated regulatory mechanisms